Regulatory Implications

Session Chairs

Valentina Colcelli, Researcher (National Research Council)

Marialuisa Lavitrano, Professor (University Milano Bicocca)

Speakers and Presentations  

• Michaela Mayrhofer, Head of ELSI (BBMRI-ERIC) - "Where are we on the Code of Conduct for Health Research?"  
• Roberto Cippitani, Professor (Università degli Studi di Perugia) - "Secondary use" in biomedical research: ethical and juridical issues"    
• Carla Barbosa, Researcher (Centro de Direito Biomédico da Faculdade de Direito de Coimbra) - "Biobanks in Europe - the need for regulatory harmonization. A post-pandemic reality."  
• Toni Fickentscher, PhD Candidate in Law (University of Regensburg) - "Cross-border research in the light of Article 9 para. lit. j) GDPR"

Session Information

The covid-19 pandemic raises significant implications for many regulatory and ethical aspects of biobanking. This year we will hold a session that takes a broader perspective than our ELSI sessions of recent years, and consider regulatory implications of diagnostics and vaccines, as well as our usual topics of data protection and consent.